CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 187 filers reported holding CRISPR THERAPEUTICS AG in Q3 2018. The put-call ratio across all filers is 2.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,199,000 | -89.0% | 85,549 | -72.2% | 0.02% | -85.5% |
| Q4 2020 | $47,054,000 | +92.0% | 307,320 | +4.9% | 0.12% | +59.0% |
| Q3 2020 | $24,510,000 | +21.3% | 293,041 | +6.6% | 0.08% | +9.9% |
| Q2 2020 | $20,204,000 | +63.5% | 274,917 | -5.6% | 0.07% | +29.1% |
| Q1 2020 | $12,357,000 | -28.2% | 291,374 | +3.2% | 0.06% | -3.5% |
| Q4 2019 | $17,202,000 | +17.5% | 282,434 | -20.9% | 0.06% | +14.0% |
| Q3 2019 | $14,634,000 | +10.2% | 357,021 | +58.0% | 0.05% | +28.2% |
| Q2 2018 | $13,278,000 | +209.6% | 225,970 | +6.7% | 0.04% | +200.0% |
| Q4 2016 | $4,289,000 | – | 211,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
| Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
| EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
| NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
| ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
| NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
| Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
| Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |